Anti-Rat CD3 FITC

Grouped product items
SizePrice Qty
50 ug
$80.00
100 ug
$140.00
500 ug
$300.00

Additional G4.18 Formats

Cat.No.FormatStarting From
05113-50FITC$ 80.00
05113-25SAFIRE Purified$ 350.00
05113-60PE$ 90.00
Catalog Number : 05113-50

description

The G4.18 monoclonal antibody specifically reacts with rat CD3, a T cell lineage marker and associated with the T cell receptor (TCR). CD3 is involved in antigen recognition, cell activation, and signal transduction and is found on subsets of NK-T, peripheral T, dendritic epidermal T, and thymocyte cells. Immobilized G4.18 antibody activates T cells in vitro and in vivo treatments of the G4.18 antibody prevents cardiac and skin allograft rejection.

Additional Information

Clone:
G4.18
Format:
FITC
Applications:
FC
Reactivity:
Rat
Isotype:
Mouse IgG3, kappa
Research Interest:Adaptive Immunity
Cell Type:NK and NKT Cells
Application:FC
Clone:G4.18
Preparation:
The product should be stored undiluted at 4°C and should be protected from prolonged exposure to light. Do not freeze. The monoclonal antibody was purified utilizing affinity chromatography and unreacted dye was removed from the product.
Formulation:
Phosphate-buffered aqueous solution, ≤0.09% Sodium azide, may contain carrier protein/stabilizer, ph7.2.
References:

Nicolls, M. R., Aversa, G. G., Pearce, N. W., Spinelli, A., Berger, M. F., Gurley, K. E., & Hall, B. M. (1993). Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody.Transplantation55(3), 459-468.

Morris, D. L., & Komocsar, W. J. (1997). Immunophenotyping analysis of peripheral blood, splenic, and thymic lymphocytes in male and female rats.Journal of pharmacological and toxicological methods37(1), 37-46.

Tran, G. T., Carter, N., He, X. Y., Spicer, T. S., Plain, K. M., Nicolls, M., ... & Hodgkinson, S. J. (2001). Reversal of experimental allergic encephalomyelitis with non-mitogenic, non-depleting anti-CD3 mAb therapy with a preferential effect on Th1 cells that is augmented by IL-4. International immunology13(9), 1109-1120.

© BioGems International, Inc. All rights reserved.